Connection

Bonaventura Clotet to HIV-1

This is a "connection" page, showing publications Bonaventura Clotet has written about HIV-1.
Connection Strength

1.047
  1. Clinically relevant thresholds for ultrasensitive HIV drug resistance testing: a multi-country nested case-control study. Lancet HIV. 2018 11; 5(11):e638-e646.
    View in: PubMed
    Score: 0.064
  2. Low nadir CD4+ T-cell counts predict gut dysbiosis in HIV-1 infection. Mucosal Immunol. 2019 01; 12(1):232-246.
    View in: PubMed
    Score: 0.063
  3. Unexpected synergistic HIV neutralization by a triple microbicide produced in rice endosperm. Proc Natl Acad Sci U S A. 2018 08 14; 115(33):E7854-E7862.
    View in: PubMed
    Score: 0.063
  4. CD32 expression is associated to T-cell activation and is not a marker of the HIV-1 reservoir. Nat Commun. 2018 07 16; 9(1):2739.
    View in: PubMed
    Score: 0.063
  5. Impact of intensification with raltegravir on HIV-1-infected individuals receiving monotherapy with boosted PIs. J Antimicrob Chemother. 2018 07 01; 73(7):1940-1948.
    View in: PubMed
    Score: 0.062
  6. Control of HIV-1 Pathogenesis in Viremic Nonprogressors Is Independent of Gag-Specific Cytotoxic T Lymphocyte Responses. J Virol. 2018 06 15; 92(12).
    View in: PubMed
    Score: 0.062
  7. Gag-protease coevolution analyses define novel structural surfaces in the HIV-1 matrix and capsid involved in resistance to Protease Inhibitors. Sci Rep. 2017 06 16; 7(1):3717.
    View in: PubMed
    Score: 0.058
  8. SAMHD1 is active in cycling cells permissive to HIV-1 infection. Antiviral Res. 2017 06; 142:123-135.
    View in: PubMed
    Score: 0.057
  9. Plasma HIV-1 Tropism and the Risk of Short-Term Clinical Progression to AIDS or Death. PLoS One. 2017; 12(1):e0166613.
    View in: PubMed
    Score: 0.057
  10. Reduced darunavir dose is as effective in maintaining HIV suppression as the standard dose in virologically suppressed HIV-infected patients: a randomized clinical trial. J Antimicrob Chemother. 2015 Apr; 70(4):1139-45.
    View in: PubMed
    Score: 0.049
  11. Functional analyses reveal extensive RRE plasticity in primary HIV-1 sequences selected under selective pressure. PLoS One. 2014; 9(8):e106299.
    View in: PubMed
    Score: 0.048
  12. Increase in transmitted resistance to non-nucleoside reverse transcriptase inhibitors among newly diagnosed HIV-1 infections in Europe. BMC Infect Dis. 2014 Jul 21; 14:407.
    View in: PubMed
    Score: 0.048
  13. Stable HIV-1 integrase diversity during initial HIV-1 RNA decay suggests complete blockade of plasma HIV-1 replication by effective raltegravir-containing salvage therapy. Virol J. 2013 Dec 05; 10:350.
    View in: PubMed
    Score: 0.045
  14. Changes in codon-pair bias of human immunodeficiency virus type 1 have profound effects on virus replication in cell culture. Retrovirology. 2013 Jul 25; 10:78.
    View in: PubMed
    Score: 0.044
  15. Pneumocystis jirovecii pneumonia in HIV-1-infected patients in the late-HAART era in developed countries. Scand J Infect Dis. 2013 Aug; 45(8):635-44.
    View in: PubMed
    Score: 0.043
  16. Evaluation of the cytopathicity (fusion/hemifusion) of patient-derived HIV-1 envelope glycoproteins comparing two effector cell lines. J Biomol Screen. 2012 Jul; 17(6):727-37.
    View in: PubMed
    Score: 0.040
  17. Genotypic and phenotypic evolution of HIV type-1 protease during in vitro sequential or concomitant combination of atazanavir and amprenavir. Antivir Ther. 2010; 15(3):431-6.
    View in: PubMed
    Score: 0.035
  18. On the steps of cell-to-cell HIV transmission between CD4 T cells. Retrovirology. 2009 Oct 13; 6:89.
    View in: PubMed
    Score: 0.034
  19. Safety of enfuvirtide in combination with an optimized background of antiretrovirals in treatment-experienced HIV-1-infected adults over 48 weeks. J Acquir Immune Defic Syndr. 2005 Dec 01; 40(4):413-21.
    View in: PubMed
    Score: 0.026
  20. Antibodies and Antibody Derivatives: New Partners in HIV Eradication Strategies. Front Immunol. 2018; 9:2429.
    View in: PubMed
    Score: 0.016
  21. Mechanisms That Contribute to a Profound Reduction of the HIV-1 Reservoir After Allogeneic Stem Cell Transplant. Ann Intern Med. 2018 11 20; 169(10):674-683.
    View in: PubMed
    Score: 0.016
  22. Dolutegravir-based maintenance monotherapy versus dual therapy with lamivudine: a planned 24 week analysis of the DOLAM randomized clinical trial. J Antimicrob Chemother. 2018 07 01; 73(7):1965-1971.
    View in: PubMed
    Score: 0.016
  23. Evaluation of the Innate Immune Modulator Acitretin as a Strategy To Clear the HIV Reservoir. Antimicrob Agents Chemother. 2017 11; 61(11).
    View in: PubMed
    Score: 0.015
  24. RNA editing by ADAR1 regulates innate and antiviral immune functions in primary macrophages. Sci Rep. 2017 10 17; 7(1):13339.
    View in: PubMed
    Score: 0.015
  25. Changes in T-cell subsets in HIV-HCV-coinfected patients during pegylated interferon-alpha2a plus ribavirin treatment. Antivir Ther. 2010; 15(3):333-42.
    View in: PubMed
    Score: 0.009
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.